Fast Money's Cancer Breakthrough Stocks
357 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
Created by barrons3
DESCRIPTION:

Date updated:06-03-2009

Mike Huckman, a CNBC business reporter, came on the show to talk about the upcoming American Society of Clinical Oncology meeting.

symbol name last price % change open
  • +
  • OSIP
    Osi Pharmaceutica
  • $32.79
  • -0.21%
  • $33.05

Huckman said some of the companies to watch are OSI Pharma(OSIP) which is expected to release test results on a cancer drug this weekend, and Medivation(MDVN), which is due to come out with some prostate cancer drug results.

People owning OSIP also tend to own: BSXOSTKARGBHIBIIBBKCCOL

TheStreet.com Rating: B- What is this?

  • +
  • MDVN
    Medivation
  • $29.22
  • +2.06%
  • $28.75

Huckman said some of the companies to watch are OSI Pharma(OSIP) which is expected to release test results on a cancer drug this weekend, and Medivation(MDVN), which is due to come out with some prostate cancer drug results.

People owning MDVN also tend to own: ACLIAPOLAUYBABYBBBYBDAYBRKA

TheStreet.com Rating: No Rating What is this?

  • +
  • GHDX
    Genomic Health
  • $19.29
  • +1.31%
  • $19.11

Genomic (GHDX) will introduce a test that may be able to determine the likelihood of colon cancer coming back and Astra-Zeneca (AZN) is expected to offer data on 3 different cancer drugs.

People owning GHDX also tend to own: ACLIAPOLAUYBABYBBBYBDAYBRKA

TheStreet.com Rating: D What is this?

  • +
  • AZN
    Astrazeneca Plc A
  • $44.82
  • -0.82%
  • $44.385

Genomic (GHDX) will introduce a test that may be able to determine the likelihood of colon cancer coming back and Astra-Zeneca (AZN) is expected to offer data on 3 different cancer drugs.

People owning AZN also tend to own: ATVIGMEAEPBACBLSDETR

TheStreet.com Rating: No Rating What is this?

Portfolio not tracked!

Comments not available

ADD YOUR COMMENTS:

Cramer's Take on Headline Stocks...

Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...

11.20.09 | 11:48 AM
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...

11.20.09 | 08:09 AM
'Fast Money' Portfolios of the Week

By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...

11.19.09 | 11:13 AM
Squeezing the Shorts: Earnings G...

By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...

11.18.09 | 12:36 PM
more articles
today 's lists
Analyst Upgrades

Analyst Upgrades or Estimate Increases for Nov. 20, 2009. Read more here. more

Rising on Unusual Volume

Here are some stocks that moved up on unusual volume on Nov. 19, 2009. more

Analyst Downgrades

Analyst Downgrades or Estimate Reductions for Nov. 20, 2009. Read more here. more